Browse thread
[Caml-list] multiple choices and simple savings
- brice douce
[
Home
]
[ Index:
by date
|
by threads
]
[ Message by date: previous | next ] [ Message in thread: previous | next ] [ Thread: previous | next ]
[ Message by date: previous | next ] [ Message in thread: previous | next ] [ Thread: previous | next ]
| Date: | -- (:) |
| From: | brice douce <banenage@p...> |
| Subject: | [Caml-list] multiple choices and simple savings |
lapmiddel~frostparamtexttele-communica`ground-dash dr`_u-gs from a`,mer_ica & 0,vernig_ht sh''ippi-'ng accra hill-basedmpjd http://pyqdhi.klr.antioch8386drygs.us/f74/ -----Original Message----- From: Darlena Robertson [mailto:gmtr@ijauxltdl.com] To: keenan mancuso; carroll waiki Sent: Tuesday, November, 2004 6:40 PM Subject: multiple choices and simple savings Should further research be conducted to assess combination versus monotherapy? Novel lactams should not be compared with older generation lactams or penicillins combined with aminoglycosides The reason for further trials assessing the addition of an aminglycoside to a lactam seems dubious as well paragranizo10surtidor52reformado,penetrabilidad monuela. ------------------- To unsubscribe, mail caml-list-request@inria.fr Archives: http://caml.inria.fr Bug reports: http://caml.inria.fr/bin/caml-bugs FAQ: http://caml.inria.fr/FAQ/ Beginner's list: http://groups.yahoo.com/group/ocaml_beginners